GU-CA-COVID: a clinical audit among Italian genitourinary oncologists during the first COVID-19 outbreak.
Melissa BersanelliSebastiano ButiMimma RizzoAlessio CortelliniCarlo CattriniFrancesco MassariCristina MasiniMaria Giuseppa VitaleGiuseppe FornariniOrazio CaffoFrancesco AtzoriAlice GattiSerena MacriniClaudia MucciariniLuca GalliFranco MorelliMarco StellatoMartina FanelliFrancesca CortiPaolo Andrea ZucaliIlaria ToscaniAlberto Dalla VoltaAngela GernoneCinzia BaldessariLeonardo La TorreDiego ZaraAlessandra GennariSergio BracardaGiuseppe ProcopioCamillo PortaPublished in: Therapeutic advances in urology (2021)
GU cancer patients undergoing active treatment with ICIs have meaningful risk factors for developing severe events from COVID-19 and permanent discontinuation of therapy after the infection. Treatment delays due to organizational issues during the pandemic were unlikely to affect the treatment outcome in this population.